These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15659121)

  • 1. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
    Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
    Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.
    Huang C; Wei P; Fan K; Liu Y; Lai L
    Biochemistry; 2004 Apr; 43(15):4568-74. PubMed ID: 15078103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
    Kuang WF; Chow LP; Wu MH; Hwang LH
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays.
    Chen L; Chen S; Gui C; Shen J; Shen X; Jiang H
    J Biomol Screen; 2006 Dec; 11(8):915-21. PubMed ID: 17092912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu LH; Choy WY; Tsai SN; Rao Z; Ngai SM
    Protein Sci; 2006 Apr; 15(4):699-709. PubMed ID: 16600962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris.
    Nguyen TT; Woo HJ; Kang HK; Nguyen VD; Kim YM; Kim DW; Ahn SA; Xia Y; Kim D
    Biotechnol Lett; 2012 May; 34(5):831-8. PubMed ID: 22350287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
    Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
    J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
    Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
    J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.
    Muramatsu T; Kim YT; Nishii W; Terada T; Shirouzu M; Yokoyama S
    FEBS J; 2013 May; 280(9):2002-13. PubMed ID: 23452147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.
    Shie JJ; Fang JM; Kuo CJ; Kuo TH; Liang PH; Huang HJ; Yang WB; Lin CH; Chen JL; Wu YT; Wong CH
    J Med Chem; 2005 Jun; 48(13):4469-73. PubMed ID: 15974598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
    Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
    J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.
    Grum-Tokars V; Ratia K; Begaye A; Baker SC; Mesecar AD
    Virus Res; 2008 Apr; 133(1):63-73. PubMed ID: 17397958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts.
    Luo W; Su X; Gong S; Qin Y; Liu W; Li J; Yu H; Xu Q
    Biosci Trends; 2009 Aug; 3(4):124-6. PubMed ID: 20103835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) .
    Barrila J; Gabelli SB; Bacha U; Amzel LM; Freire E
    Biochemistry; 2010 May; 49(20):4308-17. PubMed ID: 20420403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the maturation process of SARS-CoV 3CL protease.
    Hsu MF; Kuo CJ; Chang KT; Chang HC; Chou CC; Ko TP; Shr HL; Chang GG; Wang AH; Liang PH
    J Biol Chem; 2005 Sep; 280(35):31257-66. PubMed ID: 15788388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors.
    Yang Q; Chen L; He X; Gao Z; Shen X; Bai D
    Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1400-5. PubMed ID: 18827378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
    Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
    J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.